GLP-1 Receptor Agonists: Clinical Trial Considerations GLP-1 Receptor Agonists: Drug Litigation Overview and Trends GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs Foley is here to help you address the short- and long-term impacts in the wake of regulatory changes
Pharmacist Comment We asked Sorin Romaniuc, Pharmacist at Medino , to explain why some people might notice sleep changes when starting Mounjaro: "Vivid dreams are not a listed side effect, but it is not unusual for people to notice changes in sleep when starting a medication that affects appetite, metabolism, and weight
Patients should stop treatment and seek urgent medical advice if they experience severe, persistent abdominal pain (which may radiate to the back) or symptoms of gallbladder disease such as pain in the upper right abdomen, fever, or jaundice
What Monitoring Would Have to Look Like If a clinician does decide the combination is appropriate for a specific patient, the supervision burden is real: baseline and repeated blood pressure and heart rate checks, review of every other prescription and supplement for serotonergic or sympathomimetic overlap, attention to sleep, and a defined stopping point for the phentermine component rather than open-ended renewal
Int J Oncol 23(6):15531559 Ogawa K et al (2000) The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
